Aarón Sulkes

4.2k total citations
164 papers, 3.3k citations indexed

About

Aarón Sulkes is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Aarón Sulkes has authored 164 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 96 papers in Oncology, 44 papers in Pulmonary and Respiratory Medicine and 43 papers in Surgery. Recurrent topics in Aarón Sulkes's work include Cancer Treatment and Pharmacology (21 papers), Colorectal Cancer Treatments and Studies (20 papers) and Gastric Cancer Management and Outcomes (16 papers). Aarón Sulkes is often cited by papers focused on Cancer Treatment and Pharmacology (21 papers), Colorectal Cancer Treatments and Studies (20 papers) and Gastric Cancer Management and Outcomes (16 papers). Aarón Sulkes collaborates with scholars based in Israel, United States and Netherlands. Aarón Sulkes's co-authors include Eyal Fenig, Baruch Brenner, Erica Rakowsky, J. Wanders, Salomon M. Stemmer, Rinat Yerushalmi, Tamar Peretz, Louise Ryan, K H Antman and Anthony Elias and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Aarón Sulkes

161 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aarón Sulkes Israel 30 1.8k 984 627 465 371 164 3.3k
Guilhem Bousquet France 27 812 0.4× 672 0.7× 466 0.7× 542 1.2× 332 0.9× 116 2.7k
Peter M. Anderson United States 40 1.1k 0.6× 1.8k 1.9× 564 0.9× 1.1k 2.4× 277 0.7× 129 4.3k
Roberto Coppola Italy 32 1.5k 0.8× 870 0.9× 1.5k 2.4× 567 1.2× 137 0.4× 196 3.4k
Hans‐Joachim Stemmler Germany 27 2.0k 1.1× 981 1.0× 402 0.6× 433 0.9× 128 0.3× 97 3.4k
K. Höffken Germany 36 2.6k 1.4× 848 0.9× 425 0.7× 1.1k 2.4× 967 2.6× 186 5.4k
Federica Tomao Italy 38 2.0k 1.1× 1.0k 1.0× 949 1.5× 1.2k 2.6× 665 1.8× 243 4.9k
Ronald G. Stoller United States 27 2.0k 1.1× 535 0.5× 282 0.4× 920 2.0× 268 0.7× 63 3.5k
Courtney L. Scaife United States 29 1.5k 0.8× 829 0.8× 1.1k 1.8× 884 1.9× 83 0.2× 104 4.3k
Andrés Redondo Spain 28 1.0k 0.6× 548 0.6× 494 0.8× 895 1.9× 253 0.7× 199 3.3k
Francesco Petrella Italy 29 876 0.5× 1.8k 1.9× 624 1.0× 667 1.4× 77 0.2× 201 3.3k

Countries citing papers authored by Aarón Sulkes

Since Specialization
Citations

This map shows the geographic impact of Aarón Sulkes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aarón Sulkes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aarón Sulkes more than expected).

Fields of papers citing papers by Aarón Sulkes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aarón Sulkes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aarón Sulkes. The network helps show where Aarón Sulkes may publish in the future.

Co-authorship network of co-authors of Aarón Sulkes

This figure shows the co-authorship network connecting the top 25 collaborators of Aarón Sulkes. A scholar is included among the top collaborators of Aarón Sulkes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aarón Sulkes. Aarón Sulkes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kuchuk, Iryna, Tzippy Shochat, Aarón Sulkes, et al.. (2021). Taxane versus vinorelbine in combination with trastuzumab and pertuzumab for first-line treatment of metastatic HER2-positive breast cancer: a retrospective two-center study. Breast Cancer Research and Treatment. 188(2). 379–387. 2 indexed citations
2.
Ross, Jeffrey S., Tal Goshen‐Lago, Riad Haddad, et al.. (2020). ERBB2 Pathway in Biliary Tract Carcinoma: Clinical Implications of a Targetable Pathway. Oncology Research and Treatment. 44(1-2). 20–27. 22 indexed citations
3.
4.
Goldvaser, Hadar, Shulamith Rizel, Daniel Hendler, et al.. (2017). The association between smoking and breast cancer characteristics and outcome. BMC Cancer. 17(1). 624–624. 24 indexed citations
5.
Goldvaser, Hadar, Shulamit Rizel, Daniel Hendler, et al.. (2016). The Association between Angiotensin Receptor Blocker Usage and Breast Cancer Characteristics. Oncology. 91(4). 217–223. 4 indexed citations
6.
Brenner, Baruch, Michal Sarfaty, Ofer Purim, et al.. (2016). A Phase Ib/II Study Evaluating the Combination of Weekly Docetaxel and Cisplatin Together with Capecitabine and Bevacizumab in Patients with Advanced Esophago-Gastric Cancer. PLoS ONE. 11(7). e0157548–e0157548. 4 indexed citations
7.
Wasserberg, Nir, Ofer Purim, Yulia Kundel, et al.. (2015). Early Postoperative 18F-FDG PET/CT in High-Risk Stage III Colorectal Cancer. Clinical Nuclear Medicine. 40(4). e222–e227. 6 indexed citations
8.
Ben‐Aharon, Irit, Salomon M. Stemmer, Ofer Shpilberg, Aarón Sulkes, & Anat Gafter‐Gvili. (2013). Low molecular weight heparin (LMWH) for primary thrombophylaxis in patients with solid malignancies: Systematic review and meta-analysis.. Journal of Clinical Oncology. 31(15_suppl). e20595–e20595. 1 indexed citations
9.
Zer, Alona, Shulamit Rizel, Rony Braunstein, et al.. (2012). Tailoring Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer: A Historical Prospective Study. Chemotherapy. 58(2). 95–101. 1 indexed citations
10.
Kundel, Yulia, Ofer Purim, Efraim Idelevich, et al.. (2011). Postoperative chemoradiation for resected gastric cancer - is the Macdonald Regimen Tolerable? a retrospective multi-institutional study. Radiation Oncology. 6(1). 127–127. 13 indexed citations
11.
Sulkes, Aarón. (2010). Novel multitargeted anticancer oral therapies: sunitinib and sorafenib as a paradigm.. PubMed. 12(10). 628–32. 18 indexed citations
12.
Brenner, Baruch, et al.. (2010). Local excision after neoadjuvant chemoradiation for rectal cancer: Is it an acceptable treatment option?. Journal of Clinical Oncology. 28(15_suppl). 3646–3646. 1 indexed citations
13.
Brenner, Baruch, Sara Borok, Erica Rakowsky, et al.. (2003). Older age and second skin cancer as prognostic factors in localized malignant melanomas. Oncology Reports. 2 indexed citations
14.
Brenner, Baruch, et al.. (2002). Prediction of outcome in locally advanced breast cancer by post-chemotherapy nodal status and baseline serum tumour markers. British Journal of Cancer. 87(12). 1404–1410. 10 indexed citations
15.
Sella, Avishay, Dov Flex, Miriam Konichezky, Aarón Sulkes, & Jack Baniel. (2000). Combination Chemotherapy following Adrenal Suppression in Androgen– Independent Prostate Cancer. European Urology. 38(3). 255–258. 3 indexed citations
16.
Fenig, Eyal, et al.. (2000). Oral Etoposide for Merkel Cell Carcinoma in Patients Previously Treated With Intravenous Etoposide. American Journal of Clinical Oncology. 23(1). 65–67. 22 indexed citations
17.
Schachter, Jacob, Baruch Brenner, Eyal Fenig, et al.. (1999). Toxicity of adjuvant high-dose interferon-alpha-2b in patients with cutaneous melanoma at high risk of recurrence.. Oncology Reports. 6(6). 1389–93. 14 indexed citations
18.
Gabizon, Alberto, Rut Isacson, Eugene Libson, et al.. (1994). Clinical Studies of Liposome-Encapsulated Doxorubicin. Acta Oncologica. 33(7). 779–786. 129 indexed citations
19.
20.
Siegal, Tali, M. Raphael Pfeffer, Raphael Catane, et al.. (1983). Successful chemotherapy of recurrent intracranial germinoma with spinal metastases. Neurology. 33(5). 631–631. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guilhem Bousquet Breakdown of academic impact, for papers by Peter M. Anderson Breakdown of academic impact, for papers by Roberto Coppola Breakdown of academic impact, for papers by Hans‐Joachim Stemmler Breakdown of academic impact, for papers by K. Höffken Breakdown of academic impact, for papers by Federica Tomao Breakdown of academic impact, for papers by Ronald G. Stoller Breakdown of academic impact, for papers by Courtney L. Scaife Breakdown of academic impact, for papers by Andrés Redondo Breakdown of academic impact, for papers by Francesco Petrella
Rankless by CCL
2026